We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,074

A change for the better? The arguments for and against a Venture Exchange
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • April 22 2015

With a total of 284 U.S. operating company IPOs in 2014, the U.S. securities market might appear to be on an upswing after all, this was its biggest


U.S. Supreme Court holds agency interpretations are not subject to notice-and-comment rulemaking requirement
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • March 16 2015

In 2004, the DOL revamped its regulations regarding the Fair Labor Standards Act (FLSA) administrative exemption. In 2006, the Bush DOL issued an


Ascertainability saps plaintiffs’ energy in dietary supplement class action
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • March 4 2015

In the recent decision Mirabella v. Vital Pharmaceuticals, Inc., Case No. 12-62086-CIV-ZLOCH (S.D. Fl. Feb. 27, 2015) the plaintiffs attempted, but


4 keys to witness interviews in internal investigations
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • March 12 2015

"So you are the great lawyer I've been told about! But, you are so young! I was expecting an old lawyer." With those words, the silver-haired


Medicare Advantage insurers may see positive growth in 2016 despite CMS’ 0.95 payment rate cut announcement
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • March 5 2015

The Centers for Medicare and Medicaid Services (CMS) proposed a 0.95 percent decrease in Medicare Advantage payment rates for 2016 in its Advance


CMS’ proposed regulations include significant antitrust implications for entities interested in forming ACOs
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • January 5 2015

The Centers for Medicare & Medicaid Services (CMS) released proposed regulations to clarify and build on current regulatory requirements for


New FDA draft guidance on rems and bioequivalence studies: does new procedure secure ANDA applicants the right to obtain samples?
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • January 5 2015

Applicants seeking approval of Abbreviated New Drug Applications (ANDAs) in most cases must perform bioequivalence studies comparing their proposed


Reminder to perform annual ISOESPP reporting in January 2015
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • January 5 2015

As discussed in our December 16, 2010 blog article, the IRS issued final regulations in 2009 under Section 6039 of the Internal Revenue Code (the


AFL-CIO’s Industry Wide Agreement may have wide reach in hospitality industry
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • January 5 2015

Mid-way through 2012, the Hotel Association of New York City and the New York Hotel & Motel Trades Council, AFL-CIO (the “Union”), renewed a


Changes of the amended Regulations on Supervision and Administration of Medical Devices
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • April 16 2014

The Regulations on Supervision and Administration of Medical Devices was amended and promulgated by the State Council on March 7th, 2014, effective